SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now
EVENT Cannabis Europa London 2026 — Europe's cannabis industry unites Get Tickets

Recent Searches

    One week and one day

    By

    We are just over a week away from the US election – and the future of a legalization timeline in the US – is on the line. (Not to mention the future of democracy itself.) So, expect most of the news of the next week in the cannabis sector on what the election means for New Jersey and other states – as well as federal legalization (and the pandemic too).

    Last week on Business of Cannabis we held our Cannabis + Technology presented by CannaBusiness ERP from NexTec last week. Our entire program is now available on our website. Check it out.

    Our new publication, the Weekly Chronicle took a look at the rise of special purpose acquisitions corporations last week. Subscribe and read.

    Looking down the road a bit, stay tuned for updates about our upcoming Medical Cannabis Week November 16 through 20.

    Read on…

    In the latest issue of the Weekly Chronicle, the newest publication of Business of Cannabis, our Editor-in-Chief Jameson Berkow looks as special purpose acquisition corporations (SPAC) in the cannabis sector. Subscribe to read the full story.

    New York is looking to legalize and regulate cannabis early next year, according to the Governor. Marijuana Moment

    A Change.org petition is circulating to allow cannabis retailers in Ontario to offer curbside and delivery. Monopoly be damned… change.org

    Speaking of monopoly, category manager at the Ontario Cannabis Store Peter Shearer did an AMA on Reddit. Reddit

    Peter Shearer of the Ontario Cannabis Store hosts a Reddit AMA

    And, bringing us the really important news: Is cannabis the secret to a great first pitch? The Growth Op

    BofC

    The Briefing / Newsletter

    Insights
    you don't want
    to miss.

    A comprehensive, thoughtfully curated overview of the stories defining today's cannabis sector — breaking news, investigative features, expert commentary, and context-rich analysis to help you navigate events with clarity and confidence.

    • Policy & regulation
    • Markets & deals
    • Clinical & science
    Subscribe free